Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Gastric Dilatation D013271 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Stomach Volvulus D013277 1 associated lipids
Foot Rot D005535 1 associated lipids
Frostbite D005627 1 associated lipids
Strongyle Infections, Equine D013319 1 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Edema, Cardiac D004489 1 associated lipids
Osteoblastoma D018215 1 associated lipids
Radiculopathy D011843 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Halushka PV et al. Insulin and arachidonic acid metabolism in diabetes mellitus. 1985 Metab. Clin. Exp. pmid:3934501
Kimura Y et al. Effects of stilbenes on arachidonate metabolism in leukocytes. 1985 Biochim. Biophys. Acta pmid:3922423
Bakhle YS et al. Differential release of eicosanoids by bradykinin, arachidonic acid and calcium ionophore A23187 in guinea-pig isolated perfused lung. 1985 Br. J. Pharmacol. pmid:2996675
Panse M et al. An improved malondialdehyde assay for estimation of thromboxane synthase activity in washed human blood platelets. 1985 Prostaglandins pmid:3937179
Heinz TR et al. Radiation-induced alterations in cyclooxygenase product synthesis by isolated perfused rat lungs. 1985 Prog Biochem Pharmacol pmid:3921980
Lauri D et al. Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways. 1985 J. Lab. Clin. Med. pmid:3923145
Johnson A and Malik AB Pulmonary transvascular fluid and protein exchange after thrombin-induced microembolism. Differential effects of cyclooxygenase inhibitors. 1985 Am. Rev. Respir. Dis. pmid:3925828
Packham MA et al. Duration of the effect of aspirin on the synthesis of thromboxane by density subpopulations of rabbit platelets stimulated with thrombin. 1985 Blood pmid:3926022
Patrono C et al. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. 1985 J. Clin. Invest. pmid:3900132
Cattaneo M et al. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium. 1985 Thromb. Haemost. pmid:3927505
Aitokallio-Tallberg A et al. Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate. 1985 Br. J. Cancer pmid:2986666
Callahan KS et al. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets. 1985 Circulation pmid:2986877
Schmitz JM et al. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. 1985 Circ. Res. pmid:3926340
Apprill P et al. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. 1985 Circulation pmid:2988822
Mehta J and Mehta P Prostacyclin and thromboxane A2 production by human cardiac atrial tissues. 1985 Am. Heart J. pmid:3880988
Friedrich T et al. Follow-up of prostaglandin plasma levels after acute myocardial infarction. 1985 Am. Heart J. pmid:3880994
Wilson TW and Tan LK Low plasma renin activity in diabetes. Relation to urine prostaglandin excretion. 1985 Diabetes pmid:3881302
Longenecker GL et al. Kinetics of ibuprofen effect on platelet and endothelial prostanoid release. 1985 Clin. Pharmacol. Ther. pmid:3882308
Kuzuya T et al. Determination of plasma thromboxane B2 by radioimmunoassay: methodological problems and accuracy. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936210
Morita I et al. Effect of dietary protein level on platelet aggregation in rat. 1985 Prostaglandins Leukot Med pmid:3892545
de Lorgeril M et al. Acute influence of cigarette smoke in platelets, catecholamines and neurophysins in the normal conditions of daily life. 1985 Eur. Heart J. pmid:2937635
Lelcuk S et al. Prostacyclin and thromboxane A2 moderate postischemic renal failure. 1985 Surgery pmid:3895535
Paajanen H and Kormano M Prostacyclin (PGI2) and thromboxane (TXA2) levels during intravenous contrast medium administration in CT. 1985 Eur J Radiol pmid:3896802
Yui Y et al. A new stable prostacyclin analogue OP41483 (15-cyclopentyl-omega-pentanor-5(E)-carbacyclin). 1985 Jpn. Circ. J. pmid:3897597
Codde JP and Beilin LJ Dietary fish oil prevents dexamethasone induced hypertension in the rat. 1985 Clin. Sci. pmid:3905217
Nawroth PP et al. Thromboxane production by perturbed bovine aortic endothelial cells in culture. 1985 Blut pmid:3967102
Martin JL et al. Effect of high dose aspirin on coronary hemodynamics during pacing-induced myocardial ischemia. 1985 J. Am. Coll. Cardiol. pmid:3968305
De Caterina R et al. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. 1985 Thromb. Res. pmid:3975876
Cook JA et al. Exchange transfusions in rats with a perfluorated blood substitute: effect on thromboxane B2 levels during endotoxemia. 1985 Circ. Shock pmid:3978769
Westenfelder C et al. Renal function in calves with total artificial hearts. 1985 Trans Am Soc Artif Intern Organs pmid:3837477
Schrör K et al. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands]. 1985 Klin. Wochenschr. pmid:3838352
Bult H et al. Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid. 1985 Br. J. Pharmacol. pmid:3838489
Remuzzi G et al. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis. 1985 J. Clin. Invest. pmid:4038407
Mogensen F et al. Effect of specific thromboxane-synthetase inhibition on thromboxane and prostaglandin synthesis in stable angina induced by exercise test. 1985 Thromb. Res. pmid:4038824
Tada M et al. Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction. 1985 Int. J. Cardiol. pmid:4040500
Lorenzana RM et al. Experimental T-2 toxicosis in swine. I. Changes in cardiac output, aortic mean pressure, catecholamines, 6-keto-PGF1 alpha, thromboxane B2, and acid-base parameters. 1985 Fundam Appl Toxicol pmid:3840756
Wargovich T et al. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. 1985 J. Am. Coll. Cardiol. pmid:4045029
Elliott GR et al. Arachidonic acid, an in vivo inhibitor of carrageenin induced granulomas in the rat. 1985 Eur. J. Pharmacol. pmid:2988985
Feuerstein G et al. Effects of nafazatrom on cardiovascular, sympathetic, and endocrine responses to hemorrhagic shock in conscious rats. 1985 Circ. Shock pmid:3841032
Cerletti C et al. Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma". 1985 Thromb. Haemost. pmid:4049312
Dejana E et al. Differential salicylate-aspirin interaction on vascular prostacyclin and platelet thromboxane synthesis in patients undergoing saphenectomy. 1985 Proc. Soc. Exp. Biol. Med. pmid:3841210
Fiedler VB et al. The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury. 1985 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3841382
Palmer RM and Salmon JA Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesis. 1985 Biochem. Pharmacol. pmid:2986647
Lynch TJ et al. Carbon tetrachloride-induced eicosanoid synthesis and enzyme release from rat peritoneal leucocytes. 1985 Biochem. Pharmacol. pmid:2986650
Elliott GR et al. Changes in resident rat peritoneal macrophage eicosanoid release, induced by altering the buffer K+/Na+ ratio, are Ca2+ dependent. 1985 Biochim. Biophys. Acta pmid:3933563
Miura K et al. Effect of SA-446, an angiotensin-converting enzyme inhibitor, on renal function in anesthetized dogs: special reference to arachidonic acid metabolites. 1985 Jan-Feb J. Cardiovasc. Pharmacol. pmid:2580127
Olanoff LS et al. Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia. 1985 Jan-Feb J. Cardiovasc. Pharmacol. pmid:2580129
Hook BG et al. Experimental coronary artery thrombosis in the absence of thromboxane A2 synthesis: evidence for alternate pathways for coronary thrombosis. 1985 Jan-Feb J. Cardiovasc. Pharmacol. pmid:2580139
Fisher M and Zipser R Increased excretion of immunoreactive thromboxane B2 in cerebral ischemia. 1985 Jan-Feb Stroke pmid:3966251
Mullane KM and McGiff JC Platelet depletion and infarct size in an occlusion-reperfusion model of myocardial ischemia in anesthetized dogs. 1985 Jul-Aug J. Cardiovasc. Pharmacol. pmid:2410715
Uyama O et al. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease. 1985 Mar-Apr Stroke pmid:3883580
Fujimoto T et al. Cerebrovascular injuries induced by activation of platelets in vivo. 1985 Mar-Apr Stroke pmid:3975962
Lamy M et al. Biochemical pathways of acute lung injury. 1985 May-Jun Bull Eur Physiopathol Respir pmid:3873973
Jolly SR et al. Platelet depletion in experimental myocardial infarction. 1985 May-Jun Basic Res. Cardiol. pmid:4026785
Hillbom M et al. Effects of ethanol on platelet function. 1985 May-Jun Alcohol pmid:4026960
Codde JP et al. Changes in prostanoid synthesis in response to diet and hypertension in one-kidney, one clip rats. 1985 Nov-Dec Hypertension pmid:3908314
Nagatsuka K et al. A new approach to antithrombotic therapy--evaluation of combined therapy of thromboxane synthetase inhibitor and very low dose of aspirin. 1985 Sep-Oct Stroke pmid:3931302
Pfliegler G et al. Platelet function studies in myeloproliferative disorders. 1986 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:2435631
Bjøro K et al. Formation of prostanoids in human umbilical vessels perfused in vitro. 1986 Prostaglandins pmid:3523623
Bjøro K Prostacyclin and thromboxane formation in human umbilical arteries following stimulation with vasoactive autacoids. 1986 Prostaglandins pmid:3523624
Schleimer RP et al. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. 1986 J. Immunol. pmid:3082976
Chiricolo M et al. Prostaglandin and thromboxane biosynthesis in resting and activated platelet-free monocytes from aged subjects. 1986 Gerontology pmid:3086183
Perico N et al. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate. 1986 J. Pharmacol. Exp. Ther. pmid:3531461
Cunnane SC et al. n-3 Essential fatty acids decrease weight gain in genetically obese mice. 1986 Br. J. Nutr. pmid:3676212
Hsu CY et al. Increased thromboxane level in experimental spinal cord injury. 1986 J. Neurol. Sci. pmid:3525758
Slotman GJ et al. Thromboxane A2 mediates hemodynamic and respiratory dysfunction in graded bacteremia. 1986 Surgery pmid:3526603
Fischer S et al. Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites. 1986 Biochim. Biophys. Acta pmid:3754157
Schenkein HA LPS-stimulated release of prostaglandin E and thromboxane B2 from the U937 cell line. 1986 Cell. Immunol. pmid:3100058
Ali M and Mohammed SY Selective suppression of platelet thromboxane formation with sparing of vascular prostacyclin synthesis by aqueous extract of garlic in rabbits. 1986 Prostaglandins Leukot Med pmid:3547414
Simonson MS and Dunn MJ Leukotriene C4 and D4 contract rat glomerular mesangial cells. 1986 Kidney Int. pmid:3465969
Arai M [Plasma thromboxane B2 levels in various liver diseases]. 1986 Nihon Shokakibyo Gakkai Zasshi pmid:3735742
Schneidkraut MJ et al. Regional release of cyclooxygenase products after radiation exposure of the rat. 1986 J. Appl. Physiol. pmid:3096935
Catapano AL et al. Bile lipids, platelet aggregability and pro-ApoAI processing in 2 cases of Tangier disease. 1986 Monogr Atheroscler pmid:3736556
Semrad SD et al. Hypertension in bulls and steers anesthetized with guaifenesin-thiobarbiturate-halothane combination. 1986 Am. J. Vet. Res. pmid:3740628
Cao QL [Dynamic analysis of plasma TXB2 determined by radioimmunoassay in 30 cases of cerebral infarction]. 1986 Zhonghua Shen Jing Jing Shen Ke Za Zhi pmid:3743234
Knapp HR et al. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. 1986 N. Engl. J. Med. pmid:3007982
Ono N et al. Pharmacological studies on proglumetacin maleate, a new non-steroidal anti-inflammatory drug (4). Mode of action on anti-inflammatory activity. 1986 Jpn. J. Pharmacol. pmid:3102823
Laffi G et al. Effects of sulindac and ibuprofen in patients with cirrhosis and ascites. An explanation for the renal-sparing effect of sulindac. 1986 Gastroenterology pmid:3079594
Ishihara Y et al. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs. 1986 Prostaglandins Leukot Med pmid:3457388
Schenkein HA Prostaglandin E and thromboxane B2 release by PMA-induced U937 cells in response to C3b. 1986 J. Leukoc. Biol. pmid:3457882
Kääpä P et al. Increased platelet thromboxane B2 production in newborn infants of diabetic mothers. 1986 Prostaglandins Leukot Med pmid:3458263
Kudo K et al. [Urinary excretion of thromboxane B2 in normal human subjects: sex and age differences]. 1986 Nippon Naika Gakkai Zasshi pmid:3746076
Weiner BH et al. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. 1986 N. Engl. J. Med. pmid:3748103
Catella F et al. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3461463
DiMinno G et al. Trial of repeated low-dose aspirin in diabetic angiopathy. 1986 Blood pmid:3092890
Mueller HS et al. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin. 1986 Herz pmid:2939012
Legrand YJ et al. Activation of platelets by microfibrils and collagen. A comparative study. 1986 Lab. Invest. pmid:2939291
Connellan JM et al. Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen. 1986 Thromb. Haemost. pmid:2940722
Eldrup-Jorgensen J et al. Antiplatelet therapy and vascular grafts. Studies in a baboon ex vivo shunt. 1986 Arch Surg pmid:2940991
Arai M et al. Platelet dysfunction and alteration of prostaglandin metabolism after chronic alcohol consumption. 1986 Scand. J. Gastroenterol. pmid:3810010
Chiang TM and Kang AH The effect of platelet surface protein phosphorylation on collagen-platelet interaction. 1986 Thromb. Res. pmid:3810565
Perkett EA et al. Lymphocyte and granulocyte migration across the endothelial layer of bovine pulmonary artery intimal explants towards lymphocyte conditioned medium. 1986 Tissue Cell pmid:3810636
Cerletti C et al. Comparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in man. 1986 Agents Actions Suppl. pmid:3101444
Perico N et al. Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A. 1986 Am. J. Physiol. pmid:3094383
Gyllenhammar H et al. Essential fatty acid deficiency in rats: effects on arachidonate metabolism, generation of cyclooxygenase products and functional responses in neutrophils. 1986 Immunol. Lett. pmid:3095230
Tremoli E et al. Dietary interventions in north Karelia, Finland and south Italy. Modification of thromboxane B2 formation in platelets of male subjects only. 1986 Atherosclerosis pmid:3964338
Boukili MA et al. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade. 1986 Br. J. Pharmacol. pmid:3096407
Pohanka E and Sinzinger H Effect of a single pentoxifylline administration on platelet sensitivity, plasma factor activity, plasma-6-oxo-PGF1 alpha and thromboxane B2 in healthy volunteers. 1986 Prostaglandins Leukot Med pmid:3523540
Masi I et al. Effects of CDP-choline on platelet aggregation and the antiaggregatory activity of arterial wall in the rat. 1986 Pharmacol Res Commun pmid:3523545
Winn R et al. Lung permeability and hemodynamics during endotoxemia: effect of aprotinin. 1986 J. Surg. Res. pmid:2431222